Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.
- Published In:
- The Journal of pharmacology and experimental therapeutics, 344(1), 141-54 (2013)
- Authors:
- McCoy, Alene T, Benoist, Caroline C, Wright, John W, Kawas, Leen H, Bule-Ghogare, Jyote M, Zhu, Mingyan, Appleyard, Suzanne M, Wayman, Gary A, Harding, Joseph W
- Database ID:
- RPEP-02233
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02233APA
McCoy, Alene T; Benoist, Caroline C; Wright, John W; Kawas, Leen H; Bule-Ghogare, Jyote M; Zhu, Mingyan; Appleyard, Suzanne M; Wayman, Gary A; Harding, Joseph W. (2013). Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.. The Journal of pharmacology and experimental therapeutics, 344(1), 141-54. https://doi.org/10.1124/jpet.112.199497
MLA
McCoy, Alene T, et al. "Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.." The Journal of pharmacology and experimental therapeutics, 2013. https://doi.org/10.1124/jpet.112.199497
RethinkPeptides
RethinkPeptides Research Database. "Evaluation of metabolically stabilized angiotensin IV analog..." RPEP-02233. Retrieved from https://rethinkpeptides.com/research/mccoy-2013-evaluation-of-metabolically-stabilized
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.